Tags: Cancer | cancer | generic | drug | Doxil | FDA | shortage

Cancer Generic Approved to Ease Life-Threatening Drug Shortage

Tuesday, 05 Feb 2013 07:40 AM

 

Health regulators have approved a generic version of the cancer drug Doxil in a move that could ease a months-long shortage that has threatened the lives of thousands of patients.
 
The Food and Drug Administration said on Monday it approved a version of Doxil, known generically as doxorubicin HCI liposome injection, that is made by Sun Pharma Global FZE, a subsidiary of India's Sun Pharmaceutical Industries Ltd. It will be available in 20-milligram and 50-milligram vials.
 
Sun's product is the first generic version of Doxil, which was approved in 1995 and is used to treat ovarian cancer, AIDS-related Kaposi's sarcoma, and multiple myeloma. Doxil is made by Johnson & Johnson.
 
Doxil fell into short supply after manufacturing problems at an outside contract manufacturer, Ben Venue Laboratories Inc, a unit of German drugmaker Boehringer Ingelheim, suspended operations in November 2011 due to quality control problems.
 
Last February, the FDA allowed for the temporary importation of Lipodox, which is made by Sun and contains the same active ingredient as Doxil. The agency said it intends to continue allowing the importation of Lipodox until Sun has made enough generic Doxil to meet demand.
 
Late last month a federal judge approved a consent decree under which Ben Venue must bring its Bedford, Ohio facility into compliance with regulatory requirements or face fines and other penalties.
 
The FDA said the company had repeatedly violated good manufacturing practices. Recent inspections found that poorly maintained equipment deteriorated to the point that it shed particles into injectable drugs, the FDA said.
 
President Barack Obama made drug shortages a national priority with an executive order in October, 2011.

© 2015 Thomson/Reuters. All rights reserved.

Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Top Trainer's Step-by-Step Plan for Better Fitness

Sunday, 25 Jan 2015 11:25 AM

The excitement and anticipation surrounding the upcoming Super Bowl may prompt some people to take up anew sport or up t . . .

Tide Turning in Ebola Fight After Hard Lessons

Saturday, 24 Jan 2015 15:16 PM

A top U.N. official in the fight against Ebola greeted just three patients at one treatment center he visited this week  . . .

'Miracle' Vaccine, Drugs Will Soon Stop AIDS: Bill Gates

Saturday, 24 Jan 2015 10:18 AM

Two new tools to fight AIDS should be available by 2030 in the form of a vaccine and new intense drug treatments, ending . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved